The market for contract manufacturing of prescription drugs exceeded $30 billion last year, a 10% increase that is being fuelled …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

